Kringle Pharma: Regarding the revision of the third quarter financial results and financial estimates for the September 2024 period.

JPX · Aug 9 14:40

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.